z-logo
open-access-imgOpen Access
Taxol extravasation: A case report
Author(s) -
Wendy L. Bailey,
R. Michael Crump
Publication year - 1997
Publication title -
canadian oncology nursing journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2368-8076
pISSN - 1181-912X
DOI - 10.5737/1181912x729697
Subject(s) - extravasation , intervention (counseling) , medicine , drug , pharmacology , intensive care medicine , pathology , psychiatry
Taxol is a relatively new antineoplastic agent whose classification as either vesicant, non-vesicant, or irritant remains under debate. This case study is presented to follow a large-volume Taxol extravasation. The article illustrates assessment, follow-up, intervention and outcome of this situation. This case suggests the drug is a vesicant with the potential to cause moderate soft tissue injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here